CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
Javed SR. et al, (2024), Br J Cancer, 130, 467 - 475
Production and binding analyses of a humanised scFv against a cryptic epitope on tumour-associated fibronectin.
Johdi NA. et al, (2013), Protein Expr Purif, 88, 157 - 163
Molecular determinants of the cell-cycle regulated Mcm1p-Fkh2p transcription factor complex.
Boros J. et al, (2003), Nucleic Acids Res, 31, 2279 - 2288